Carlson S A, Chatterjee T K, Fisher R A
Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
J Biol Chem. 1996 Sep 20;271(38):23146-53. doi: 10.1074/jbc.271.38.23146.
Platelet activating factor (PAF) is a potent phospholipid mediator which elicits a diverse array of biological actions by interacting with G protein-coupled PAF receptors (PAFR). Binding of PAF to PAFRs leads to activation of G protein(s) that stimulate phosphoinositide phospholipase C and subsequent intracellular signaling responses. To identify the potential role of intracellular domains of the rat PAFR (rPAFR) in signaling, we examined effects of transfecting minigenes encompassing rPAFR intracellular domains 1 (1i), 2 (2i), and 3 (3i) on inositol phosphate (IP) production mediated by the co-transfected rPAFR cDNA. Although transfection of the rPAFR1i and rPAFR2i minigenes had no effects on PAF-stimulated signaling, transfection of the rPAFR3i minigene inhibited PAF-stimulated IP production by approximately 50% compared to controls. The rPAFR3i domain did not inhibit IP production mediated by the multifunctional rat pituitary adenylate cyclase-activating polypeptide receptor (rPACAPR), demonstrating the specificity of the competition by the rPAFR3i domain. In further experiments, the rPAFR3i domain was engineered onto the homologous domain of a monofunctional transmembrane variant of the rPACAPR (rPACAPR2) that activates only adenylyl cyclase. The rPACAPR2/rPAFR3i chimera responded to PACAP with increases in IP production which were attenuated nearly completely in cells cotransfected with the rPAFR3i domain. In contrast, PACAP had no effects on IP production in a receptor chimera expressing a mutated form of the rPAFR3i domain (rPACAPR2/rPAFR3imut). These results demonstrate the ability of the rPAFR3i domain to confer a phospholipase C-signaling phenotype to a receptor deficient in this activity and show that this activity is specific for the engineered rPAFR3i domain. These results suggest that the third intracellular loop of the rPAFR is a primary determinant in its coupling to phosphoinositide phospholipase C-activating G proteins, providing the first insight into the molecular basis of interaction of PAFRs with signal-transducing G proteins.
血小板活化因子(PAF)是一种强效磷脂介质,它通过与G蛋白偶联的PAF受体(PAFR)相互作用引发多种生物学效应。PAF与PAFR的结合会导致G蛋白激活,进而刺激磷酸肌醇磷脂酶C并引发后续的细胞内信号反应。为了确定大鼠PAF受体(rPAFR)细胞内结构域在信号传导中的潜在作用,我们研究了转染包含rPAFR细胞内结构域1(1i)、2(2i)和3(3i)的小基因对共转染的rPAFR cDNA介导的肌醇磷酸(IP)产生的影响。尽管转染rPAFR1i和rPAFR2i小基因对PAF刺激的信号传导没有影响,但与对照相比,转染rPAFR3i小基因可使PAF刺激的IP产生减少约50%。rPAFR3i结构域并未抑制多功能大鼠垂体腺苷酸环化酶激活多肽受体(rPACAPR)介导的IP产生,这证明了rPAFR3i结构域竞争的特异性。在进一步的实验中,将rPAFR3i结构域构建到仅激活腺苷酸环化酶的rPACAPR单功能跨膜变体的同源结构域上。rPACAPR2/rPAFR3i嵌合体对PACAP的反应是IP产生增加,而在与rPAFR3i结构域共转染的细胞中,这种增加几乎完全减弱。相反,PACAP对表达rPAFR3i结构域突变形式的受体嵌合体(rPACAPR2/rPAFR3imut)中的IP产生没有影响。这些结果证明了rPAFR3i结构域赋予缺乏该活性的受体磷脂酶C信号表型的能力,并表明这种活性对工程化的rPAFR3i结构域具有特异性。这些结果表明,rPAFR的第三个细胞内环是其与磷酸肌醇磷脂酶C激活G蛋白偶联的主要决定因素,为PAFR与信号转导G蛋白相互作用的分子基础提供了首个见解。